Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Medipharm Labs Corp T.LABS

Alternate Symbol(s):  MEDIF

MediPharm Labs Corp. is a Canada-based full-service pharmaceutical company. The Company specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API) and advanced derivative products. Through its wholesale and white label platforms, the Company formulates, develops (including through sensory testing), processes, packages and distributes cannabis extracts and advanced cannabinoid-based products to domestic and international markets. It also provides GMP flower sourcing, packaging, and distribution services for select international clients. In addition, it cultivates cannabis to sell as dried flower, pre-roll and other cannabis products for the adult use and medical markets. It also sells metered dose inhalers and aerosol sublingual sprays. Through Harvest Medicine, it provides clinic services to Canadian patients requiring medical cannabis education and prescriptions.


TSX:LABS - Post by User

Comment by mdjbrownon Oct 31, 2023 10:22am
99 Views
Post# 35709104

RE:RE:RE:Possibilities are endless as CBD is tested and I dont think

RE:RE:RE:Possibilities are endless as CBD is tested and I dont thinkIn a nutshell okgonow, its called manipulation, and it has been going on for a long time holding Labs shareprice back.

Not sure why or by who, but when taking into account the lowest Medipharm's shares have ever dropped is .055 cents on fairly limited volume, the profit margin for those selling at .075, is minimal.

It cant be shorts as short interest has declined substantially in recent reporting periods to less than a million shares held short.
MEDIPHARM LABS CORP. 855,673 -293,872 14 Oct 2023


So either a group of current unknowns are accumulating shares for that big announcement, or there are other motives by those in the know for suppressing the share price.
<< Previous
Bullboard Posts
Next >>